Skip to main content
. 2017 Aug 14;9(7):1076–1087. doi: 10.1080/19420862.2017.1364325

Figure 9.

Figure 9.

Suggested decision tree during lead identification of bivalent and multivalent antibodies (Ab) for the determination of the relevant in vivo interaction mode and the identification of the candidate with the optimal binding strength. Check points involving the conversion of the bivalent and multivalent antibodies to Fabs are highlighted in green. *In the case of a monovalent target and an available assay excluding avidity (e.g., using the soluble monovalent target in solution), the Ab to Fab conversion may be omitted.